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What Are Prions? 
 
Over 30 years ago, it was proposed that a protein could be an agent of infection 
if it could exists in a self-propagating infectious form (Griffen, 1967).  A prion 
(proteinaceous infectious particles) is a protein isoform that has undergone changes 
that diminish its ability to perform its normal function, but enables it to convert the 
normal form of the protein into the prion isoform (Wickner and Chernoff, 1999).  The 
term, prion, was originally proposed by S. Prusiner to explain the unusual transmission 
pattern of neurodegenative diseases (Prusiner, 1982).    
The prion concept reveals a new method of inheritance independent of nucleic 
acid or amino acid sequences, but instead, will efficiently transfer from cell to cell by 
cytoplasmic mixing.  Neither the genetic sequence nor the amino acid sequence is 
changed, but the prion is passed to progeny cells in a non-Mendelian pattern of 
segregation in meiosis in yeast cells.  A single copy of a genetic element will result in a 
2+:2- segregation.  The mating of a cell containing the prion element with one that lacks 
the prion element produces mietotic offspring which all contains the prion element.  This 
is a 4+: 0 segregation (Cox et al., 1988). 
Prions form highly ordered insoluble aggregates, called amyloids, that seem to 
reproduce themselves by dissociating into smaller oligomers that serve as seeds to 
new rounds of prion propagation. The formation of aggregates is associated with a 
conformational change in the secondary structure resulting in increase of ß-sheet 
structures in the effected protein.  This conformational shift can be induced by the over 
production of the normal cellular protein. 
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An additional characteristic of a prion is the curability by exposure to non-
mutagenic substances, such as guanine hydrochloride, and re-infection independent of 
exposure to another cell.  The cured cell should be capable of producing prion-
containing progeny in a manner dependent only upon the production of the normal 
cellular protein.  
 
Prion diseases 
The prion concept was first used to explain pathogen transmission consistent 
with bovine spongiform encephalopathy (BSE), sheep scapie disease, and human 
Creutzfeldt-Jacob disease.  The cellular protein, PrPC, normally located on the cell 
surface, is converted to an abnormal isoform PrPSc.  Both isoforms have the same 
amino acid sequence and can be distinguished from each other by structure alone.  The 
non-infectious form of PrP contains mostly alpha helical structures.  This is in contrast to 
the infectious form with in rich in B-structures (Pan 1993).  PrPC is monomeric and 
remain soluble in non-denaturing detergents, and is degradable by proteases.  PrPSc is 
an insoluble aggregate that is resistant to proteaolysis (Prusiner, 1994). 
The accumulation of insoluble protein aggregates is associated with amyloidosis 
such as Alzheimers disease, neuro inclusion disorders such as Amyotrophic Lateral 
Sclersosis, and polyglutamine diseases such as Huntingtons disease.  Although these 
diseases are non-infectious, the autocatalyzed misfolding, perpetuation of incorrect 
conformation and aggregation of proteins is consistent with the prion concept observed 
in transmission of BSE.  The presence of aggregates is a prominent cytopathological 
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feature of many neurodegenerative diseases, and has been associated with the 
inhibition of certain cellular functions (Bence et al., 2001). 
 
Prions in Yeast 
 Three of the best-characterized prions of Saccharomyces cerevisiae are [PSI+], 
[URE3], and [PIN+].  [URA3] is a prion form of the protein Ure2 that is a posttranslational 
regulator in the nitrogen metabolism pathway.  Because of the partial loss of function of 
Ure2, in the presence of [URA3], cells are able to uptake ureidosuccinic acid from the 
media.  These cells are then able to use ureidosuccinic acid as a source of uracil 
(Lacroute, 1971).   
The prion [PIN+] is the isoform of the protein Rnq1, and this proteins function is 
unknown.  The presence of the prion [PIN+] is necessary for the de novo formation of 
the prion [PSI+] (Derkatch et al., 1997).  [PSI+] is the prion isoforms of the protein Sup35 
that functions as a eRF3 translational termination factor.  The presence of [PSI+] is 
detected by the partial loss of function of Sup35. 
All three of these protein elements are inherited in a non-Mendelian manner and 
require the nuclear elements for maintenance, URA2 gene in the case of [URA3], 
(Wickner, 1994) the N terminus of the SUP35 gene in the case of [PSI+] (Doel et al., 
1994), and RNQ1 in the case of [PIN+].  All three are reversibly curable using agents 
such as guanidine hydrochloride, and the prion form can be induced by the over 
expression of the related genetic element. The majority of the related protein is found in 
an insoluble, protease resistant, aggregated form in cells that are phenotypically 
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consistent with the presence of the prions.  Most of the related protein is found in the 
insoluble form in cells that are not suspect for the presence of the prions. 
 
The Yeast Prion [PSI+] 
 The structure of an eRF1 protein mimics that of a tRNA molecule.  It recognizes 
the stop codon and catalyzes the hydrolysis of the bond between the nascent 
polypeptide and tRNA.  eRF3 is a GTPase that binds  to eRF1  facilitating its release 
activity.( Zhouravleva et al., 1995)  In yeast eRF3 is encoded by the SUP35 gene. 
(Zhouravleva et al.,1995; Stansfield et al.,1995)  Mutations in either SUP35 or SUP45, 
which codes for eRF1, results in suppression of nonsense codons (Inge-Vechtomov and 
Andrianova, 1970). 
 Sup35 protein consists of three regions.  The C-proximal region is the most 
conserved and is required for viability and termination.  The N-proximal portion is not 
required for viability or termination, but in necessary for the propagation, induction and 
maintenance of [PSI+] (Derkatch et al., 1996). The M region, middle region, is not 
directly required for proper function of the protein nor is it responsible for [PSI+] 
propagation, maintenance or induction.  The minimal region of the Sup35 protein 
required for the induction of [PSI+] is the first 61 amino acids of the N-region, and the 
first 97 amino acids are required for [PSI+] maintenance.   
 The self-propagation of the prion isomers may be responsible for the partial loss 
of function of Sup35.  As new Sup35 is created, it is converted to the prion 
conformation, and then incorporated into aggregates, which interferes with its ability to 
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perform as a translational release factor (Paushkin et al.,1997).  This loss of function is 
also self perpetuating and becomes a heritable change (Patino et al., 1996). 
The Yeast Prion [PIN+] 
 The over production of Sup35 or Sup35N induces the de novo formation of [PSI+] 
in [psi-] strains.  In most cases, this induction is dependent upon the presence of an 
additional prion [PIN+] (Derkatch et al., 1997).   De novo formation of [PSI+] is 
dependent upon the prion [PIN+], but the maintenance of [PSI+] is not dependent upon 
the presence of [PIN+].   
 [PIN+] is the prion isoforms of the protein, Rnq1. Deletion of gene that codes for 
Rnq1 eliminates [PIN+] phenotype, but other prions, such as [URA3] can substitute of 
[PIN+] in rnq1∆ strains (Derkatch et al., 2001).  The deletion of the URA3 gene, in these 
circumstances, eliminates the [PIN+] phenotype.  This interaction among these prions 
suggests that self-propagating protein structures may perform functions yet unknown 
throughout many eukaryotic cells. 
 
Prions and Chaperones 
 The concentration of proteins in the cellular plasma is extremely dense, and 
nascent proteins, in order to function properly, need to obtain their native structures 
while in this highly competitive environment.  Chaperones are a group of proteins that 
facilitate the proper folding of nascent proteins, to prevent the aggregation of denatured 
and damaged proteins, to aide in the correction of misfolded proteins, and to assist in 
the elimination of proteins that cannot be properly refolded (Gottsman et al. 1997).  
Protein aggregation is a common cellular event, and occurs at a magnified level during 
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thermal and oxidative stress (Fink, 1998). The chaperone system is instrumental in 
preventing the accumulation of aggregates within the cell. 
 How can prions form under the action of the many chaperones used to control 
protein aggregation?  In the case of induction by over expression of the genetic element 
related to prion development, the major facilitator could be the over whelming number of 
nascent proteins is too great for the system.  The lack of action of the chaperone 
system upon nascent proteins may allow for the development of the prion isoforms.  
The self-propagating property of this isoforms further facilitates the development of the 
aggregate by its contact with nascent, unfolded proteins or proteins that have already 
taken on the native conformation. 
 In the case of the extremely rare spontaneous occurrence of prions, where over 
production of proteins is not a factor; the protein control system may have an occasional 
error that allows the creation of the self-propagating isoform of a protein.  This allows for 
the exponential creation of proteins that are in the prion isoform and that readily 
aggregate.  The correction of excessive misfolded proteins in conjunction with the 
normal function may again over whelm the chaperone system. 
 
Hsp104 and [PSI+] 
The chaperone, Hsp104, belongs to an evolutionary conserved Hsp100 family of 
proteins that participate in a various number of cellular processes (Schirmer et al., 
1996).  Hsp104, in particular, is responsible for the cells adaptation to heat shock, it 
controls spore viability and the long-term viability of starving vegetative cells.  (Sanchez 
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and Linquist,  1990; Sanchez  et al.,1992)  It is an ATPase that has been shown to 
promote solubilization of aggregated protein (Parsel et al., 1991). 
A unique relationship exists between Hsp104 levels within the cell and the 
maintenance of the prion [PSI+].  The over production of Hsp104 eliminates [PSI+] 
(Chernoff 1995). This seems logical considering Hsp104 is a disaggregase, and it is 
reasonable to assume that the over production provides sufficient resources to break 
the aggregates into portions that are accessible to either other chaperones which would 
facilitate the proper folding or perhaps the system responsible for the elimination of 
unusable proteins, such as the ubiquitin-proteasome system.   
What is both unique and counter-intuitive is the elimination of [PSI+] by the 
inhibition of elimination of Hsp104.   The disaggregase activity of Hsp104 may allow the 
propagation of [PSI+] by facilitating the seeding of daughter cells.  When the action of 
Hsp104 is inhibited or eliminated, the strong tendency for prion isoforms to aggregate 
may decrease the available proteins to the extent that none are passed to the daughter 
cells but remain in the aggregated form in the mother cell and are lost in cell division 
(Paushkin et al., 1996).   
It is necessary to note that the conditions that induce Hsp104, such as mild heat 
shock sporulation, or incubation in the stationary phase do not cure cells of  [PSI+].   
This suggests that other proteins or changes associated with these conditions could 
influence the Hsp104 effects on [PSI+]. 
 
 8
Hsp70 Proteins and [PSI+] 
 The major cytosolic subfamily of the Hsp10 family in yeast is Ssa.  It includes 
four closely related homologous proteins, Ssa1,2,3, and 4  Like Hsp104, the level of 
Ssa proteins is increased with temperature, stationary phase and sporulation. Ssa1 
protein participates in disaggregating and refolding of heat damaged protein 
agglomerates.   However, the over production of Ssa prevents efficient [PSI+] curing by 
the over production of Hsp104.The high ordered structure of prion aggregates may 
cause Hsp70-Ssa protein to recognize them as legitimate sub cellular structures rather 
than the disorganized aggregates formed by general misfolded proteins.  It may actually 
help to convert Sup35 back to the prion state promoting prion propagation (Chernoff, 
2000).  
 Ssb1 and Ssb2 are also members of the Hsp-70 family.  They are constitutively 
expressed and are not essential for viability.    Genetic and biochemical data suggest 
that Ssb proteins are involved in cotranslational folding of nascent polypeptides and 
protein turnover (Nelson 1992; Pfund et al., 1998; Obha 1997).  The over production of 
Ssb proteins enhances the curing ability of Hsp104 while the deletion inhibits curing. 
Both spontaneous [PSI+] formation and induction by over production of Sup35 in 
increased in ssb1,2∆ strains (Chernoff et al., 1999). Figure 1.1 illustrates the possible 
role of refolding in curing by Hsp104. 
 The two major subfamilies of the Hsp70 family, Ssa and Ssb, have functionally 
diverged from each other in regard to their roles in prion formation and propagation. Ssb 
protein is involved in a proofreading system that is aimed at the prevention of the 
















































































































































































































































































































 The ubiquitin system is a highly conserved, multi-enzyme system that is found in 
all eukaryotes.  Its function if primarily to target proteins for proteolytic degradation 
(Varshavsky et al., 2000; Hochstrasser, 1996). This system plays a major role in many 
biological processes such as cell differentiation, the cell cycle, apoptosis, signal 
transduction, DNA repair, transmembrane and vesicular transport, stress responses as 
well as degradation of ubiquitin-conjugated proteins by the 26S proteasome  
(Varshavsky 1997).  Figure 1.1 demonstrates the proposed role of degradation in curing 
by Hsp104.  Figure 1.2 illustrates the recycling of ubiquitin within the degradation 
pathway.  It can be seen that by the potential for inhibition of this pathway exists either 

























Figure 1.2.  The Ubiquitin System.  The ubiquitin molecule is 
recycled.  First it is activated by E1, conjugated to the targeted 
protein by E2, and is then removed prior or during degradation 
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 The primary element of the system is a 76-residue protein that exists in cells 
either free or covalently linked to other proteins. Ubiquitin is activated for conjugation to 
other proteins by a ubiquitin-activating enzyme (E1) and then moved to an ubiquitin 
cunjugatin enzyme (E2). The E2 enzyme, along with an E3 enzyme involved in 
recognition, attaches the ubiquitin to a Lysine residue of an acceptor protein, yielding an 
ubiquitin-protein conjugate (Varshavsky 1997). 
Ubiquitin is a long-lived, recycled protein.  It must be removed from the ubiquitin-
protein conjugates before or during degradation.  This is accomplished by and number 
of deubiquitinating enzymes (Dubs).  The best characterized of the 17 Dubs of 
Saccharomyces cerevisiae, is Doa4.  A significant fraction of the enzyme has been 
found associated with the 26S proteasome.  In exponentially growing cultures of doa4 
mutants, small ubiquitinated species accumulate; these species were suggested to be 
the proteolytic remnants of ubiquitinated proteins (Papa and Hochstrasser, 1993; Papa 
et al.,1999).  Also ubiquitin pools in the mutant become depleted, particularly in 
stationary-phase cultures as a result of the proteolysis of ubiquitin.  Partial suppression 
of the ubiquitin depletion by mutations in components of the 26S proteasome suggests 









 All yeast strains used in this study are listed in table 2.1.  Single deletions listed 
were accomplished using a PCR-mediated gene deletion protocol (Longtine et al.1998).  
A more detailed protocol is provided in the methods section.  Double and triple deletion 
strains were obtained through mating appropriate knock-out strains and dissecting the 




Strain Genotype References 
GT81-1C MAT a  ade1-14  his3-∆200 or 11,15  leu2-3,112  lys2  
trp1-∆  ura3-52  [PSI+][PIN+] 
Chernoff et al., 2000 
GT159 MAT a  ade1-14  his3-∆200 or 11,15  leu2-3,112  lys2  
trp1-∆  ura3-52  [psi-] [PIN+] 
Chernoff et al, 1999 
GT409 MAT a  ade1-14  his3-∆200 or 11,15  leu2-3,112  lys2  
trp1-∆  ura3-52  [psi-] [pin-] 
Chernoff et al, 1999 
GT349 MAT a  ade1-14  his3-∆200 or 11.15  leu2-3,112  lys2  
trp1-∆  ura3-52 ubc4::HIS3 [psi-] [PIN+] 
This study. See Appendix 
GT386 MAT a  ade1-14  his3-∆200 or 11.15  leu2-3,112  lys2  
trp1-∆  ura3-52 ubc4::HIS3  [PSI+] [PIN+] 
This study.  See Appendix 
GT387 MAT a  ade1-14  his3-∆200 or 11.15  leu2-3,112  lys2  
trp1-∆  ura3-52 ubc4::HIS3 [psi-] [pin-] 
 This study.  See 
Appendix 
GT532-9C MAT α ade1-14  his3-∆200 or 11.15  leu2-3,112  lys2  
trp1-∆  ura3-52 ubc4::HIS3 [PSI+] [PIN+] 
This study.  See Appendix 
OT116 MAT a  ade1-14  his3-∆200 or 11,15  leu2-3,112  lys2  
trp1-∆  ura3-52  ubp6::HIS3  [PSI+] [PIN+] 
Chernova et al., 2003 
OT117 MAT a  ade1-14  his3-∆200 or 11,15  leu2-3,112  lys2  
trp1-∆  ura3-52  ubp6::HIS3 [psi-] [PIN+] 
Chernova et al., 2003 
GT685 MAT a  ade1-14  his3-∆200 or 11,15  leu2-3,112  lys2  
trp1-∆  ura3-52  ubp6::HIS3 [psi-] [pin-] 
This study.  See Appendix 
OT144 MAT α ade1-14  his3-∆200 or 11,15  leu2-3,112  lys2  
trp1-∆  ura3-52 ubp4 :: HIS5Sp   [PSI+] [PIN+] 
Chernova et al., 2003 
GT147 MAT a  ade1-14  his3-∆200 or 11,15  leu2-3,112  lys2  
trp1-∆  ura3-52 MAT a ssb1::HIS33 ssb2::URA3  
[PSI+] [PIN+] 
Chernoff et al, 1999 
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Table 2.1 Continued 
GT823 MAT a ade1-14   leu2-3, 112  his3-∆200(or 11,15) 
lys2 trp1-∆ ura3-52 ubc4::HIS3 ssb1::HIS3 
ssb2::URA3 [psi-] [PIN+] 
This study.  See Appendix 
GT858 MAT a ade1-14   leu2-3, 112  his3-∆200(or -11, 
15) lys2 trp1-∆ ura3-52 ubc4::HIS3 ssb1::HIS3 
ssb2::URA3 [psi-] [pin-] 
This study.  See Appendix
GT563 MAT a  ade1-14  his3-∆200 or 11,15 leu2-3,112  lys2  
trp1-∆  ura3-52 rnq::HIS3    [PSI+] 
This study.  See Appendix 
GT564 MAT a  ade1-14  his3-∆200 or 11,15 leu2-3,112  lys2  
trp1-∆  ura3-52  14  rnq1:: HIS3   [psi-] 
This study.  See Appendix 
GT832-7B MAT a ade1-14  leu2-3, 112  his3-∆200(or -11, 15)  
lys2   trp1-∆   ura3-52 ubp6::HIS3 ubc4::HIS3  [PSI+] 
[PIN+] 
This study.  See Appendix 
GT949 MATa ade1-14  leu2-3, 112  his3-∆200(or -11, 15)  
lys2   trp1-∆   ura3-52 ubp6::HIS3 ubc4::HIS3 Ψ-[PIN+] 
This study.  See Appendix 
GT950 MATa ade1-14  leu2-3, 112  his3-∆200(or -11, 15)  
lys2   trp1-∆   ura3-52 ubp6::HIS3 ubc4::HIS3 [psi-] 
[pin-] 
This study.  See Appendix 
GT784-8B MAT a ade1-14  his3-∆200 or 11,15  leu2-3,112 lys2  
trp1-∆ ura3-52  ubc4::HIS3 rnq1::HIS3  [PSI+] [PIN+] 
This study.  See Appendix 
GT389-14A MAT a  ade1-14   leu2-3, 112  his3-∆200(or -11, 
15) lys2  trp1-∆   ura3-52 ubc4::HIS3 ssb1::HIS3 
ssb2::URA3  [PSI+] [PIN+] 
This study.  See Appendix 
GT784-8C MATα ade1-14  his3∆ (or 11,15) leu2-3,112 lys2  trp1-
∆ ura3-52  ubc4::HIS3 rnq1::HIS3  [PSI+] 
This study.  See Appendix 
GT820 MAT a ade1-14 his3∆ (or 11,15) lys2 ura3-52 leu2-
3,112 trp1 ubc4::HIS3  rnq1::HIS3 [psi-] 
This study.  See Appendix 
GT684-5B MAT a ade1-14   leu2-3, 112  his3-∆200(or -11, 15)   
lys2 trp1-∆ ura3-52 ubp6::HIS3 ubp4::HIS3  [PSI+] 
[PIN+] 
This study.  See Appendix 
OT37 MATα his4 lys2 S. Liebman  
 











Plasmid Protein Type Marker Promoter Source 
pFL39  Vector CEN TRP  Bonneaud, et al., 1991 
YEp13 Vector 2 micron LEU2  Ma et al., 1987 
pRS316GAL Vector CEN URA3  Liu et al., 1992 
pGAL104-
URA3 HSp104 CEN URA3 GAL 
Sanchez et al., 
1993 
pLH105 HSp104 2 micron LEU2 GPD Chernoff et al., 1999 
PFL39-
HSP104GAL HSP104 CEN TRP GAL 






Transformation of Yeast Cells by Lithium-Acetate Treatment 
  
 Strains are pre-cultured overnight for two days, depending upon growth rate, in 
5-10 mls of complete media.  The pre-cultures are diluted with fresh media, by 3 to 10 
fold, and then cultured for an additional 3-5 hours until the cells have re-entered 
exponential growth phase verified by an OD600 of 1.0-5.0.  Cells are collected by 
centrifugation at 3000 rpm (6000g).  The cells are washed with TE (10mM Tris-HCl, 
pH7.5, 1mM EDTA) and re-suspended in 5-10mls of 100mM LiAc-TE, and then cultured 
for an hour at 30oC while shaken at 200 rpm.  The cells are again collected by 
centrifugation at 3000 rpm for 5 minutes. The cells are then transferred to microfuge 
tubes (50-100 µl cells per tube) containing 20ul of carrier DNA and 1-10 µg of 
transforming DNA.  Microfuge tubes are incubated for 45 minutes at 30oC.  Following 
incubation, 350ul of LiAc-PEG (40%PEG 3350, 100mM LiAc, 10mM Tris-HCl, pH7.5, 
1mM EDTA) is added per 50 µl of cells.  After one hour of incubation and agitation by 
shaking at 30o and 200rpm, the cells are heat shocked at 42oC for 5 minutes.  The cells 
are left, at a minimum, for an hour, or overnight at 4oC.  At this point cells can be plated 
on complete media and cultured at 30oC overnight, and then velveteened onto media 
selective for the inserted DNA, or they can be plated directly upon the selective media. 
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PCR-Mediated Gene Transplacement 
 Gene deletion strains, used in this study, were created using the PCR-based 
gene deletion protocol described by Longtine et al. (1998)  Primers are designed that 
have 5 ends that contain 40 base pair sequences that are homologous to the target 
gene and 3 ends that anneal to and allow PCR amplification of the selectable marker 
gene from a template plasmid cassette.  The amplified disruption fragment is then 
transformed directly into yeast cells by using the previously described transformation 
procedure with the exception of the transforming DNA concentration.  All of the 
fragment generated by PCR is used in the transformation procedure, or the fragments 
from several PCR reactions may be pooled and precipitated by ethanol.  The 
transformation product is plated on YPD, and after incubation, is velveteened to media 
selective of the marker used to displace the gene.  The selective media plates are 
incubated at standard conditions for 3-5 days, and then duplicated once again on the 
selective media. 
 If homologous recombination takes place, the target gene will be transplaced by 
the amplified cassette containing the marker gene.  Two passes on the selective media 
eliminates cells that have not truly incorporated the maker gene.  The transplacement is 
then verified through PCR and/or by restriction analysis. 
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Mating of Yeast Strains 
 Haploid yeast strains are one of two switchable mating types, MAT a and MATα.  
Diploid strains are heterozygous, MATa/MATα.  Mating of haploid strains was carried 
out according to convention as described in Kaiser et al, 194.  Haploid parental strains 
were streaked together on YPD media and cultured at 30oC overnight.  If each haploid 
contains convenient markers, the mating plate can be duplicated on media selective for 
diploids.  In some cases, the genotypes of the haploids do not provide such convenient 
markers.  In this situation, cells are again mated to tester strains that contain makers 
different from the haploids.  Cells that fail to mate with the tester strains of either mating 
type are selected as diploids resulting from the original mating.  This procedure is 








Strains of opposite mating 
type are streaked together 
Cells from mating plate 
are streaked to obtain 
isolated colonies 
Selected colonies 









duplicated onto lawns 
of haploids of opposite 
mating types and 
different genotypes. 
Patches that formed 
diploids with testing mating 
strains, were not diploids 
at initial mating.  These 
patches are not selected. 
Figure 2.1.  Selection of diploids resulting from the mating of haploids 
whose genotypes lack markers that can be used for diploid selection.  
Patches that fail to grow in the last step of this procedure are diploids that 
were formed on the initial mating plate. 
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Tetrad Dissection and Analysis 
 
1. Diploids are placed upon a rich pre-sporulation media for 1 day and incubated at 
30oC, then velveteened onto sporulation media which provides limited nutritional 
resources and incubated for 3-5 days until a sufficient number of cells have 
sporulated. (a minimum of 40%). 
2. Cells are then subjected to lyticase treatment (1mg/ml) for 3-5 minutes at room 
temperature to remove cell wall and weaken the ascus. 
3. Lyticase digestion is halted by collection of cells at 300 rpm for 2 minutes, and then 
by resuspension in sterile water. 
4. A small portion of the cells are placed upon a small slab of YPD and dissected into 
their individual spores using a micromanipulator. 
5. The spores are incubated at 30oC until colonies are formed. 
 
Construction of Double Knockout Strains  
 
 The double knockout strains for this study were generated by crossing two 
isogenic strains with deletions of different alleles resulting in a diploid heterozygous for 
each deletion.  The diploids were sporulated and dissected. In these cases, the single 
deletion strains were constructed using the same HIS3 marker cassette, so 
identification of segragants containing both deletions was accomplished by selecting 
tetrads that exhibited a 2:2 segregation of the HIS+ phenotype. 
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Qualitative Curing of [PSI+] by HSP104 expressed under the GPD 
Promoter 
 
1. Transform strains with a YEp13 and pLH105 plasmids using the lithium acetate 
procedure.  Select for transformants on media lacking leucine. 
2. Patch selected colonies of each plasmid/strain combination onto Leu media and 
culture using standard conditions for 3-5 days. 
3. Duplicate Leu plate on YPD, YPG, -Leu Ade, and Ade media and culture 
selective media plates for 3-5 days at standard conditions.  Culture the YPD plate 
at 25oC for 3-5 days then move to 4oC and wait for color to develop. 
4. Compare growth on Ade media and color development on YPD to evaluate 
curing. 




Qualitative Curing of [PSI+] by HSP104 expressed under GAL 
Promoter 
 
1. Transform strains with a pRS316GAL and pGAL104 plasmids using the lithium 
acetate procedure.  Select for transformants on media lacking leucine. 
2. Patch selected colonies of each plasmid/strain combination onto Ura media and 
culture using standard conditions for 3-5 days. 
3. Duplicate Ura plate on YPD, YPG, -URA GAL, Ade-Ura, and Ade media and 
culture the Ura GAL plates for 5 days at standard conditions, and the other 
selective media is cultured 3-5 days at standard conditions.  Culture the YPD 
plate at 25oC for 3-5 days then move to 4oC and wait for color to develop. 
4. Compare growth on Ade and color on YPD to check for curing. Use growth on 
YPG to eliminate petites. 
5.  Duplicate the Ura GAL plate to YPD and Ade.  Culture the Ade at standard 
conditions for 3-5 days, and culture the YPD plate at 25oC for 3-5 days then 
move to 4oC and wait for color to develop. 
6. Compare growth on Ade and color on YPD to check for curing. 
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Quantitative Curing of [PSI+] by HSP104 expressed under the GAL Promoter 
 
 
1. Transform strains with a pRS316GAL and pGAL104 plasmids using the lithium 
acetate procedure.  Select for transformants on media lacking uracil. 
2. Patch selected colonies of each plasmid/strain combination onto Ura media and 
culture using standard conditions for 3-5 days. 
3. Duplicate Ura plate onto Ura, YPD, YPG, and Ade media. Culture selective 
media for 3-5 days at standard conditions.  Culture the YPD plate at 25oC for 3-5 
days then move to 4oC and wait for color to develop 
4. Select three PET+ colonies will be selected using YPG.  These colonies should 
show no evidence of curing. 
5. Use cells from each selected colony to inoculate 10 mls of liquid Ura media and 
culture 24 hours at standard conditions. 
6. Centrifuge cultures at 3000 rpm for 5 minutes and remove supernatant. 
7. Resuspend cells in 5 ml of sterile water, and centrifuge again. 
8. Resuspend cells in 3 ml of sterile water.  Transfer 1 ml of cells to a microfuge 
tube. 
9. Create serial dilutions of each cells from each colony, and perform cell counts 
using a hemocytometer. 
10.  Use cell counts to create time zero plates containing approximately 300 cells per 
plate, and to inoculate 150 mls of liquid Ura, 2% GAL, 2% RAF media to the 
concentration of 1.0 x 105 cells per ml. 
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11.  Culture the flasks of liquid cultures at standard conditions, then remove 1 ml 
from each to create serial dilutions.  These will be used for cell counts to plate 
approximately 300 cells per plate onto  Ura media.  This will be repeated for 
each time point 
12.  Culture the Ura plates for 3-5 days at 30oC. 
13.  Duplicate these plates by velveteen onto Ade and YPD. 
14.  Incubate Ade plates at 30oC for 3-5 days.  Culture the YPD plate at 25oC for 3-
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Figure 2.2.  Assay to detect [PSI+].  Functional Sup35 stops translation at a 
nonsense mutation in the ADE1 gene.  This causes a development of red 
pigment on YPD and prohibits growth on Ade media.  When Sup35 is not 
functional, there is a read through of the nonsense mutation allowing 
production of functional Ade1.  This eliminates pigment development and 
permits growth on Ade. 
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The structure of eRF1 protein mimics that of a tRNA molecule.  It recognizes the 
stop codon and catalyzes the hydrolysis of the bond between the nascent polypeptide 
and tRNA.  eRF3 is a GTPase that binds  to eRF1  facilitating its release activity.( 
Zhouravleva, 1995)  In yeast eRF3 is encoded by the SUP35 gene. (Zhouravleva 1995; 
Stansfield 1995)  Mutations in either SUP35 or SUP45, which codes for eRF1, results in 
suppression of nonsense codons. (Inge-Vechtomov 1970) 
The self-propagation of the prion isomers may be responsible for the partial loss 
of function of Sup35.  As new Sup35 is created, it is converted to the prion 
conformation, and then incorporated into aggregates which interferes with its ability to 
perform as a translational release factor.(Paushkin 1997)  This loss of function is also 
self perpetuating and becomes a heritable change. (Patino, 1996). 
A nonsense mutation in the ADE1 gene provides an assay using this loss of 
function to detect the presence of [PSI+].  When Sup35 is functional, a truncated version 
of the Ade1 protein is produced.  An accumulation of the precurser in this pathway 
creates a red pigment , and the elimination of this functional protein prohibits growth on 
media lacking adenine.  When Sup35 is not functional, the nonsense mutation is read 
through creating a fully functional Ade1 protein.  This permits growth on media lacking 
adenine, and eliminates the pigment development on YPD. 
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Viability Study of doa4∆ Strain 
1. [PSI+] and [psi-] versions of isogenic DOA4+ strains and the doa4∆ strains were 
streaked from 70oC stock collection onto YPD and cultured at 30oC for 3 days. 
2. Isolated colonies were patched on YPD, cultured for 3 days, then velveteened 
onto YPG to select for PET+ cells. 
3. The PET+ cells are used to inoculate 10 mls of liquid SD+13 (synthetic media 
containing all necessary elements per the genotype of the strain). 
4. A 500 ul aliquot of each culture is used to create serial dilutions.  Cell counts 
were performed using a hemocytometer, and cells were plated on SD+13 agar in 
a concentration to allow 300 cells per plate. 
5. At indicated time points, aliquots were taken and cell counts were performed.  
Sufficient cells were plated on SD+13 to allow approximately 300 cells per plate 
of the DOA4+ strain, and 300, 600,1500, 3000 and 6000  of the doa4∆ strains.  
6. Percentage of viable cells was calculated by dividing the number of anticipated 
colonies by the number of colonies that developed. 
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Spontaneous Occurrence of [PSI+] 
1. Cells of each strain to be tested are obtained from 70oC stock collection and 
cultured on YPD for 3 days. 
2. Isolated colonies of each strain is used to create patches of equal size on YPD 
and the plates are cultured for 2 days. 
3. The YPD plates are duplicated by velveteen onto media lacking adenine. 
4. The Ade plates are cultured for 20 days at 30oC. 
5. Small pink papillae are counted as occurrences of [PSI+]. 
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Chapter Three 
Results and Conclusions 
 





The [PSI+][PIN+] versions of a UBC4+, RNQ1+ strain, a ubc4∆ strain, a 
rnq1∆ strain, and the ubc4, rnq1∆ strain were transformed with a plasmid 
containing HSP104 expressed under the GPD promoter and a LEU marker, 
pLH105, and also a control plasmid that contained only the LEU marker, YEp13.  
Several colonies were selected from the transformation plates and were patched 
onto media lacking leucine.  These plates were cultured at standard conditions 
for 5 days, and were then duplicated by velveteen onto YPG, media lacking 
adenine, media lacking leucine, media lacking both adenine and leucine, and 
YPD.  The curing was assessed by examining the color of the patches on YPD 
and growth on media lacking adenine. (For a detailed protocol, see Materials and 
Methods) As seen in figure 3.1, ubc4∆ strains were partially cured and UBC4+ 





 The absence of RNQ1 had no detectable effect on efficiency of curing by 
HSP104 expressed under the GPD promoter.  As expected the ubc4∆ strains 
were cured at a lower efficiency compared to wild type, and this remained true 
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when rnq1 was also deleted. This suggest that the function of Rnq1 protein is not 
one involved in curing of [PSI+] by Hsp104..  This result may also indicate that 

















































Figure 3.1.  Curing of ubc4, rnq1∆ strain by HSP104 expressed under the GPD
Strains GT81-1C, UBC4+, RNQ1+, GT349, ubc4∆,  GT563, rnq1∆, and GT784-8B, 
ubc4,rnq1∆ were transformed with Yep13,an empty vector plasmid and pLH105, 
the plasmid expressing HSP104 under the GPD promoter.  Transformants were 
cultured on media lacking leucine and then duplicated by velveteen onto media 
lacking adenine and YPD.  All patches of UBC4+ cells appear completely cured.  
They are red on YPD, and fail to grow on Ade media. The patches of ubc4∆ cells 
are partially cured.  The deletion of rnq1 does not appear to effect curing efficiency.
-Ade 
YPD 












The [PSI+][PIN+] versions of a UBC4+, RNQ1+ strain, a ubc4∆ strain, a 
rnq1∆ strain, and the ubc4, rnq1∆ strain were transformed with a plasmid 
containing HSP104 expressed under the Galactose promoter and a URA 
marker,pGAL104,  and also a control plasmid that contained only the URA 
marker,pRS316GAL.  Several colonies were selected from the transformation 
plates and were patched onto media lacking uracil.  These plates were cultured 
at standard conditions for 5 days, and were then duplicated by velveteen onto  
media lacking uracil with galactose as sole carbon source.  These plates are 
cultured for 5 days and then duplicated onto YPD and media lacking adenine.  
The curing was assessed by examining the color of the patches on YPD and 
growth on media lacking adenine. (For a detailed protocol, see Materials and 
Methods) As seen in figure 3.2, ubc4∆ strains appear to have less red cells on 
YPD and slightly more growth on media lacking adenine than the UBC4+ strains.   
 
Conclusion 
 Curing by HSP104 expressed under the galactose promoter is not 
effected by the deletion of rnq1.  Curing is decreased in both ubc4∆ strains 
independent of the presence of the Rnq1 protein.  Curing is similar in rnq1∆ and 
RNQ1+ strains.  The function of Rnq1 is not involved in the curing of [PSI+] by the 












Figure 3.2. Curing of ubc4, rnq1∆ strain by HSP104 expressed under the 
Galactose Promoter Strains GT81-1C, UBC4+, RNQ1+, GT349, ubc4∆,  GT563, 
rnq1∆, and GT784-8B, ubc4,rnq1∆ were transformed with pRS316GAL,an empty 
vector plasmid and pGAL104, the plasmid expressing HSP104 under the 
galactose promoter for 5 days.  Transformants were cultured Ura media and 
then duplicated by velveteen onto Ura media with galactose as the sole carbon 
source and cultured for 5 days.  This plate was duplicated one Ade media and 
YPD.  All patches of UbC4+ cells appear only partially cured by color on YPD after 
1 week. The patches of ubc4∆ appear less cured.  On Ade media after 5 days, a 
greater portion of curing seems to be apparent, but there is still less curing in the 
















Isolated colonies of a RNQ1+, UBC4+ strain, an ubc4 ∆ strain, a rnq1 ∆ 
strain, and an ubc4, rnq1 ∆ strain were used to create patches of approximately 
the same size on YPD.  These plates were cultured using standard conditions for 
3 days, and then duplicated by velveteen upon the selective media lacking 
adenine.  The Ade plates were cultured using standard conditions for 20 days. 
  There are two types of papillae that develop.  The larger white papillae 
are not curable by GuHCl, and are therefore, assumed to be tRNA suppressor 
mutations.  The smaller pink papillea are curable by GuHCl, so are considered to 
be indicative of the presence of the prion, [PSI+]. 
As predicted from previous experimentation, spontaneous [PSI+] was a 
relatively rare event in the RNQ+, UBC4+ strains.  Papillae appear at a much 
lower frequency when the prion [PIN+] is absent.   Previous repetitive 
experimentation has shown that the papillation occurs at a much higher rate in 
both the [PIN+] and the [pin-] strains in the absence of ubc4.  The patches in 
figure 3.3 show that these results are consistent with the papillation predicted for 





































There was absence of any papillae in the ubc4, rnq1 double deletion 
strain, and very little papillation was evident in the rnq1 ∆ strain.  This is best 
illustrated in figure 4.  The only growth evident in the ubc4,rnq1 ∆ strain patch,   
is those consistant with tRNA suppressor mutations that are not curable by 
GuHCl. The spontaneous occurrence of [PSI+] in independent of the presence of 
[PIN+] in the absence of ubc4, but this pathway of prion formation is dependent 
upon some action of the Rnq1 protein. 
   
Wild Type 
ubc4 ∆ 
ubc4, rnq1 ∆ 
 
rnq1 ∆ 
Figure 3.3. Spontaneous Occurrence of [PSI+] in the ubc4, rnq1∆ strain 
 The [psi-],[pin-] strains GT409, UBC4+, RNQ1+, GT387, ubc4∆, GT564, rnq1∆, 
and GT830, ubc4,rnq1∆  were patched on YPD and allowed to grow for 3 days, 
then duplicated on Ade media.  After 20 days, it became evident that the double 
deletion strain had relatively less papillae than that of WT or either single deletion 
strains.  This illustrates the requirement for the Rnq1 protein for the formation of 







 The function of the Rnq1 protein has yet to be determined.  It is known 
that the prion form of Rnq1, [PIN+], is required for the de novo formation of [PSI+] 
induced by the over production of Sup35.  Also, in most strains, the spontaneous 
occurrence of [PSI+] is extremely rare in [pin-] strains when compared to their 
[PIN+] versions.  The ubc4∆ strain is an exception in which the substantial 
increase of spontaneous [PSI+] appearance is independent of the presence of 
[PIN+].  This research shows that the rnq1∆ strain is comparable to wild type 
such that the occurrence of spontaneous [PSI+] is rare.  However, when both 
ubc4 and rnq1 are absent, the development of [PSI+] cells is totally eliminated. 
    Efficiency of curing by Hsp104 is not effected in the rnq1∆ strain 
unlike the ubc4 deletion strain in which curing is decreased.  Toxicity caused by 
the over expression of SUP35 in [PSI+] strains is also unaffected by the deletion 
of either ubc4 or rnq1.  This data suggests that the function of Rnq1 is related 
specifically to the pathway responsible for the spontaneous occurrence of [PSI+]. 
Table 3.1: Spontaneous Occurrence of [PSI+] in the ubc4 ∆, rnq1∆ Strain 
The number of papillae counted on patches Ade media 
Genotype RNQ1+, UBC4+ rnq1∆ ubc4∆ ubc4∆, rnq1∆ 
5 2 1 3 
1 6 53 0 
0 15 150 0 
7 30 76 0 
4 2 75 1 
0 3 4 0 
Number of 
Papillae 
 0  0 
Average 2.83 8.29 59.83 0.57 
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The [PSI+][PIN+] versions of a UBC4+, SSB1,2+ strain, a ubc4∆ strain, a 
ssb1,2∆ strain, and the ubc4, ssb1,2∆ strain were transformed with a plasmid 
containing HSP104 expressed under the GPD promoter and a LEU marker, 
pLH105, and also a control plasmid that contained only the LEU marker,Yep13.  
Several colonies were selected from the transformation plates and were patched 
onto media lacking leucine.  These plates were cultured at standard conditions 
for 5 days, and were then duplicated by velveteen onto YPG, media lacking 
adenine, media lacking leucine, media lacking both adenine and leucine, and 
YPD.  The curing was assessed by examining the color of the patches on YPD 
and growth on media lacking adenine. (For a detailed protocol, see Materials and 
Methods) As seen on the Ade plate in figure 3.4, both the deletion of ubc4 and 
ssb1,2 decrease curing by HSP04 over expression.  This effect is much stronger 
in the triple deletion strain and is seen well on both the YPD and the  - Ade plate.   
 38
Figure 3.4. Curing of ubc4, ssb1,2∆ strain by HSP104 expressed under the GPD 
promoter. Strains GT81-1C, UBC4+, SSB1,2+, GT349, ubc4∆,  GT147, ssb1,2∆, and 
GT7389-14A, ubc4,ssb1,2∆ were transformed with YEp13,an empty vector plasmid and 
pLH105, the plasmid expressing HSP104 under the GPD promoter for 5 days.  Transformants 
were cultured on Leu media and then duplicated by velveteen onto Ade media and YPD.  
The Ade was cultured for 7 days, and the YPD was cultured at standard conditions for 3 
days and then placed at 4oC for 1 week for color development. The ssb1,2∆  and wild type 
cells appear completely cured. The ubc4∆ cells are only partially cured.  Curing is almost 

















The deletion of ubc4 may have decreased curing by inhibiting the pathway 
that leads to protein degradation.   The deletion of ssb1 and ssb2 decreased 
curing by Hsp104 by disabling the pathway in which proteins are refolded.  The 
absence of SSB1,2 and UBC4 significantly reduced curing.  The functions of two 
pathways involved in curing by Hsp104 are disabled in the triple deletion strain. 
This effect is sufficiently strong to be easily detected even when HSP104 is 
expressed at a relatively much greater level as in PGPD-HSP104. 
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The [PSI+][PIN+] versions of a UBC4+, SSB1,2+ strain, a ubc4∆ strain, a 
ssb1,2∆ strain, and the ubc4, ssb1,2∆ strain were transformed with a plasmid 
containing HSP104 expressed under the Galactose promoter and a TRP marker, 
pFL39-HSP104GAL and also a control plasmid that contained only the TRP 
marker., pFL39  Three colonies that were PET+ and TRP+ were selected and 
cultured in liquid media containing galactose as the sole carbon source and 
lacking tryptophan.  One-milliliter aliquots were taken at zero time point, at 24 
hours, and then again at 54 hours.  Cells were plated onto media selective for the 
plasmid from serial dilutions and allowed to culture at standard conditions for 5 
days.  These plates were duplicated by velveteen onto YPD and media lacking 
adenine. The colonies judged as cured of [PSI+] failed to grow on media lacking 
adenine and also developed a red color on YPD.  (For a detailed protocol, see 






































































































































































































































































































































































































































































































Repetitive previous experimentation, throughout this project,  has shown 
that curing by the over expression of HSP104 is decreased in the ubc4∆ strain 
when ralative to the UBC4+ strain.  Similarly, curing is also decreased in the 
ssb1,2 ∆ strain.  At all time points examined, curing was further decreased in the 
strain in which all three genes, ubc4, ssb1,and ssb2  were deleted.  There was 
no evidence of curing in any of the colonies that contained the empty vector 
plasmid. (Data not shown) These results suggest that curing is being decreased 






 Ubc4 is one of the enzymes responsible for the conjugation of the 
ubiquitin tag to proteins marked for degradation by the proteasome.  The 
decreased efficiency of curing by Hsp104 suggests the utilization of the 
degradation pathway during Hsp104 curing.   
The Ssb proteins are involved in cotranslational folding of nascent 
polypeptides (Neilson et al, 1992, Cell).  It has been previously shown that curing 
efficiency is decreased in the ssb1,2 ∆ background (Newnan et al, 1999, MCB). 
The decrease in efficiency of curing in the ssb1,2 ∆ strain suggests that curing by 
Hsp104 simultaneously utilizes this folding pathway in addition to the degradation 
pathway. 
The model in figure 3.6 illustrates the alternate destinations of Sup35 
protein after its release from the aggregate facilitated by the action of Hsp104.  
The deletion of ubc4 inhibits the degradation path, and the deletions of the 
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ssb1,2 genes inhibit the refolding path.  The triple deletion strain creates a 
compounded inhibitory effect because both pathways are negatively modified 
















Figure 3.6.  Model proposing two pathways involved in curing by 
Hsp104. This model proposes how curing can occur by two pathways.  
Both pathways are initiated by the disaggregase action of Hsp104.  In 
one pathway the misfolded Sup35 is degraded by the action of the  
ubiquitin-proteasome pathway.  The other is the correction in the folding 












Isolated colonies of both [PIN+] and [pin-] versions of [psi-]  SSB1,2+, 
UBC4+ strains, a ubc4∆ strain,  ssb1,2∆ strains, and  ubc4, ssb1,2∆ strains were 
used to create patches of approximately the same size on YPD.  These plates 
were cultured using standard conditions for 3 days, and then duplicated by 
velveteen upon the selective media lacking adenine.  The Ade plates were 
cultured using standard conditions for 20 days.  The smaller pink papillea were 
counted as spontaneous occurrences of [PSI+].  
As predicted from previous experimentation, spontaneous [PSI+] was a 
relatively rare event in the SSB1,2+, UBC4+ strains on either plates containing 
[PIN+] or [pin-] versions of the strain.  The ubc4∆ strains had a  significantly 
greater number of papillae  independent of the presence of [PIN+].   The ssb1,2∆  
strain had occurrences of [PSI+] similar to that of the wild type strains  All ubc4∆ 
strains had increased papillation independent of both [PIN+] and the presence of 
SSB1 and SSB2.  The deletion of ssb1 and ssb2 seem to have no effect upon 








Table 3.2. Spontaneous Occurrence of [PSI+] in the [PIN+] ubc4, ssb1,2 ∆ strains
GT159, SSB1,2+, UBC4+, GT408, ssb1,2∆, GT386, ubc4∆ and GT823, ubc4, ssb1,2∆ 
strains were used to create patches of equal size on YPD and cultured at standard 
conditions for 2 days.  The YPD plates were duplicated by velveteen on Ade media 
and cultured for 20 days. The small pink papillae were counted and recorded for each 
patch.   The wild type and the ssb1,2∆  strains show a similar rate of [PSI+] occurrence. 
Likewise both strains with the deletion of ubc4 show an increase occurrence relative to 
wild type.  The ubc4, ssb1,2∆ deletion strain showed a slight increase of papillae when 
compared to the ubc4∆ strain, but this difference does not even represent a 2 fold 
increase, so it may not be significant. 
Table 3.3.  Spontaneous Occurrence of [PSI+] in the [pin-] ubc4, ssb1,2 ∆ 
strains. GT409, SSB1,2+, UBC4+, GT175, ssb1,2∆, GT387, ubc4∆ and GT858, 
ubc4, ssb1,2∆ strains were used to create patches of equal size on YPD and 
cultured at standard conditions for 2 days.  The YPD plates were duplicated by 
velveteen on Ade media and cultured for 20 days. The small pink papillae were 
counted and recorded for each patch.   The wild type and the ssb1,2∆  strains show 
a similar rate of [PSI+] occurrence.  Likewise both ubc4∆ strains show an increase 
occurrence relative to wild type independent of the presence of SSB1 and SSB2. 
 
The number of papillae counted on patches of [PIN+] strains on Ade media 
Genotype SSB1,2+, UBC4+ ssb1,2∆ ubc4∆ ubc4, ssb1,2∆ 
4 8 50 >300 
8 14 >300 40 
9 5 57 53 
10 10 54 >300 
7 6 56 150 
4 5 51 65 
Number of 
Papillae 
 7  250 
Average 5.67 7.86 94.67 165.43 
 
The number of papillae counted on patches of [pin-] strains on Ade media 
Genotype SSB1,2+, UBC4+ ssb1,2∆ ubc4∆ ubc4, ssb1,2∆ 
16 29 68 58 
30 24 46 62 
17 17 >300 89 
15 19 50 70 
33 9 63 150 
24 22 51 51 
Number of Papillae 
 16  37 




 The spontaneous occurrence of [PSI+] is greater in the ubc4∆ strain, and 
this increase in independent of the presence of the prion [PIN+].  There is no 
effect when SSB1 or SSB2 are deleted.  The mechanisms responsible for 
spontaneous [PSI+] are not dependent upon the action of the Ssb proteins. 
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The [PSI+][PIN+] versions of a UBC4+, UBP6+ strain, a ubc4∆ strain, a 
ubp6∆ strain, and the ubc4, ubp6∆ strain were transformed with a plasmid 
containing HSP104 expressed under the GPD promoter and a LEU marker, 
pHS105, and also a control plasmid that contained only the LEU marker, YEp13.  
Several colonies were selected from the transformation plates and were patched 
onto media lacking leucine.  These plates were cultured at standard conditions 
for 5 days, and were then duplicated by velveteen onto YPG, media lacking 
adenine, media lacking leucine, media lacking both adenine and leucine, and 
YPD.  The curing was assessed by examining the color of the patches on YPD 
and growth on media lacking adenine.   (For a detailed protocol, see Materials 
and Methods) 
 There was no obvious difference between any strains when cured by the 
high level of Hsp104 from plamsid PGPD-Hsp04.  In figure 3.7, all strains appear 
to be completely cured when looking at color on YPD.  There is some evidence 
of [PSI+] cells when looking at the cells transformed with pLH105 on the Ade 









Figure 3.7. Curing of ubc4, ubp6∆ strain by HSP104 expressed under the GPD
Promoter. Strains GT81-1C, Wild Type, GT349, ubc4∆, OT116, ubp6∆, and GT684-
8B,ubc4,ubp6∆ were transformed with YEp13, an empty vector plasmid and pLH105, the
plasmid expressing HSP104 under the GPD promoter for 5 days. Transformants were
cultured on Leu media and then duplicated by velveteen onto Ade media and YPD.  The
ubp6∆ and wild type cells appear completely cured. The ubc4∆ cells are only partially cured.
All strains appear to cure at similar rates on the YPD plate, but the ubc4∆,strain has more
growth on Ade media. YPD was cultured at standard conditions for 2 days and then placed













 Curing by HSP104 under the GPD promoter does not seem to be 
significantly reduced in any of the test strains.  The high expression level allowed 
by the PGPD-HSP104 promoter may mask effects that are not of sufficient 
strength to overcome the strong curing effect.  This does not eliminate the 
possible role of the Ubp6 protein in Hsp104 curing, the results only show that the 
effect of the deletion of ubp6 is not strong enough to be detected when using the 
GPD promoter. 
  





The [PSI+][PIN+] versions of a UBC4+, UBP6+ strain, a ubc4∆ strain, a 
ubp6∆ strain, and the ubc4,ubp6∆ strain were transformed with a plasmid 
containing HSP104 expressed under the Galactose promoter and a URA3 
marker,pGAL104, and also a control plasmid that contained only the URA3 
marker, pRS316GAL.  Three colonies that were rho+ and URA+ were selected 
and cultured in liquid media containing 2% galactose as the sole carbon source 
but lacking uracil.  One-milliliter aliquots were taken at zero time point, at 24 
hours, 48 hours and then again at 80 hours.  Serial dilutions were made and cells 
were plated onto media selective for the plasmid and allowed to culture at 
standard conditions for 5 days.  These plates were duplicated by velveteen onto 
YPD and media lacking adenine. The colonies judged as cured of [PSI+] failed to 
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grow on media lacking adenine and also developed a red color on YPD.  (For a 
detailed protocol, see Materials and Methods) 
Curing by the over expression of HSP104 is decreased in the ubc4∆ strain 
when compared to the UBC4+ strain.  These results show that curing is also 
decreased in the ubp6∆ strain.  At 22 hours and also at 48 hours curing is 
decreased further in the double deletion strain relative to wild type and both 
single deletion strains.  At the 80 hour time point, curing is decreased in all three 
mutant strains relative to wild type.  There was no evidence of curing in any of 
the colonies that contained the empty vector plasmid or at the zero time point.   
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 The enzyme Ubc4 is one of the enzymes responsible for the conjugation of 
ubiquitin to the protein targeted for degradation by the proteasome.  Ubp6 removes the 
ubiquitin tag prior to degradation allowing the ubiquitin to re-enter the cycle.  In ubp6∆ 
strains, pools of free ubiquitin are reduced as a result of the degradation of the ubiquitin 
by the proteasome.  When conjugation of ubiquitin is decreased in a background of 
decreased ubiquitin concentration, fewer proteins are able to enter the degradation 
pathway leading to degradation by the proteasome. 
 The efficiency of curing is similarly decreased in both the ubc4∆ strain and the 
ubp6∆ strain, as could be predicted by the known function of each of the proteins.  The 
interaction between ubc4∆ and ubp6∆ is epistatic:  Curing in the double deletion strain 
occurs at a efficiency similar to that of the single deletion of ubc4.  This is also 
predictable when the function of the proteins is considered, as they work in the same 








Isolated colonies of both [PIN+] and [pin-] versions of [psi-]  UBP6+, UBC4+ 
strains, a ubc4∆ strain,  ubp6∆ strains, and  ubc4, ubp6∆ strains were used to create 
patches of approximately the same size on YPD.  These plates were cultured using 
standard conditions for 3 days, and then duplicated by velveteen upon the selective 
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media lacking adenine.  The Ade plates were cultured using standard conditions for 20 
days.  The smaller pink papillae were counted as spontaneous occurrences of [PSI+].  
As predicted from previous experimentation, spontaneous [PSI+] was a relatively 
rare event in the UBP6+, UBC4+ strains on both the plates containing [PIN+] an [pin-] 
versions.  The ubc4∆ strains had a significantly greater number of occurrences of [PSI+] 
independent of the presence of [PIN+].   The ubp6∆ strain had occurrences of [PSI+] 
similar to that of the wild type strains.  All ubc4∆ strains had increased papillation 
independent of both [PIN+] and the presence of UBP6 and SSB2.  The deletion of ssb1 
and ssb2 seem to have no effect upon the spontaneous occurrence of [PSI+]. 
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Table 3.4. Spontaneous Occurrence of [PSI+] in the [PIN+] ubc4, ubp6∆ strains
GT159, SSB1,2+, UBC4+, OT117, ubp6∆, GT386, ubc4∆ and GT949, ubc4, ubp6∆ 
strains were used to create patches of equal size on YPD and cultured at standard 
conditions for 2 days.  The YPD plates were duplicated by velveteen on Ade and 
cultured for 20 days. The small pink papillae were counted and recorded for each 
patch.   The wild type and the ubp6∆ strains show a similar rate of [PSI+] occurrence.  
Likewise both strains with the deletion of ubc4 show an increase occurrence relative to 
wild type.   
Table 3.5. Spontaneous Occurrence of [PSI+] in the [pin-] ubc4, ubp6∆ strains. 
GT409, UBP6+, UBC4+, GT685, ubp6∆, GT387, ubc4∆ and GT950, ubc4, ubp6∆ 
strains were used to create patches of equal size on YPD and cultured at standard 
conditions for 2 days.  The YPD plates were duplicated by velveteen on Ade and 
cultured for 20 days. The small pink papillae were counted and recorded for each 
patch.   The wild type and the ubp6∆ strains show a similar rate of [PSI+] 
occurrence.  Likewise both ubc4∆ strains show an increase occurrence relative to 






The number of papillae counted on patches of [PIN+] strains on Ade media 
Genotype UBP6+, UBC4+ ubp6∆ ubc4∆ ubc4, ubp6 ∆ 
2 5 36 32 
7 15 >300 40 
9 5 62 42 
5 8 47 56 
12 4 >300 64 
9 11 26 76 
Number of 
Papillae 
 6  22 







The number of papillae counted on patches of [pin-] strains on Ade media 
Genotype UBP6+, UBC4+ ubp6∆ ubc4∆ ubc4, ubp6 ∆ 
18 9 54 56 
20 12 43 72 
22 5 21 62 
2 7 19 22 
0 3 70 76 
6 0 87 92 
Number of Papillae 
 4  42 





 The spontaneous occurrence of [PSI+] is greater in the ubc4∆ strain, and this 
increase is independent of the presence of the prion [PIN+].  There is no effect when 
ubp6 is deleted.  It is possible that the deletion of this gene does not produce a 
decrease in the free ubiquitin pool sufficient to see an effect on spontaneous [PSI+].  
The phenotypes associated with the deletion of genes coding for DUBs, de-
ubiquitinating enzymes are much stronger in doa4∆ strains, but because of the defect of 
suppression in this strain, it is not possible to examine the spontaneous occurrence of 
[PSI+]. 
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Curing of doa4∆ and ubp6∆ strains by HSP104 expressed under the 
GPD promoter and comparison of suppression 
 
Results 
The [PSI+][PIN+] versions of a UBP6+, DOA4+ strain, a ubp6∆ strain, and dao4∆ 
strain, were transformed with a plasmid containing HSP104 expressed under the GPD 
promoter and a LEU marker and also a control plasmid that contained only the LEU 
marker.  Several colonies were selected from the transformation plates and were 
patched onto media lacking leucine.  These plates were cultured at standard conditions 
for 5 days, and were then duplicated by velveteen onto YPG, media lacking adenine, 
media lacking leucine, media lacking both adenine and leucine, and YPD.  The curing 
was assessed by examination of the color of the patches on YPD and growth on the 
media lacking adenine.   
 The strain containing the wild type genes and the ubp6∆ strain were 
completely cured by Hsp104.  This is evident by both color on YPD and by lack of 
growth on media lacking adenine.  Color development on YPD shows a slight 
decreased in curing in the doa4∆ strain when compared to the ubp6∆ strain and the 
strain containing with wild type genes.  This difference is not seen on media lacking 
adenine because growth of the doa4∆ strain is severely decreased on  media lacking 
adenine due to the strong defect in nonsense suppression consistent with this strain.   
 
Conclusion 
The lack of expected growth on media lacking adenine is characteristic of a 
suppression defect.  The Ade1-14 nonsense mutation is not suppressed sufficiently in 
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the [PSI+] version, so translation of the Ade1 gene does not permit production of the full-
length protein at a level equivalent to that of either the wild type strain or the ubp6∆ 
strain.  Comparison of the [psi-] doa4∆ with the [PSI+] patches shows that curing can be 
assessed efficiently by color on YPD, but not efficiently on media lacking adenine. 
Both UBP6 and DOA4 are de-ubiquitinating enzymes.  The doa4∆ strain shows 
stronger phenotypes than that of the ubp6∆ strains.   Temperature sensitivity, growth on 
media with galactose as the only carbon source and loss of viability at stationary phase 
are all phenotypes that are strongly evident in the doa4∆ strain (data shown in separate 
section of results).   This suggests that the deletion of doa4 decreases the pool of free 
ubiquitin to a greater extent than that of the deletion of ubp6. 
A decreased pool of ubiquitin available for conjugation should have a similar 
effect as the deletion of a ubiquitin conjugating enzyme.  Both mutations result in an 
inhibition of the conjugation of ubiquitin to the protein substrate.  The YPD plate in figure 
shows that, as expected, curing is decreased in the doa4∆ deletion strain, but not in the 
ubp6∆ strain where the ubiquitin pools may not be sufficiently decreased to inhibit 









pHL105 YEp13  
Figure 3.9. Curing of doa4∆ and ubp6∆ strains by HSP104 expressed under the GPD 
promoter and comparison of suppression. Strains GT81-1C, Wild type, OT116, ubp6∆, 
and OT144, doa4∆ were transformed with YEp13, an empty vector plasmid and pLH105, 
the plasmid expressing HSP104 under the GPD promoter.  Transformants were cultured on 
Leu media and then duplicated by velveteen onto Ade and YPD.  The ubp6∆ and wild 
type cells appear completely cured. The doa4∆ cells appear partially cured on YPD. The 
suppression defect prevents adequate assessment of curing of this strain.  Color on YPD 
can be used to determine the status of [PSI+]. YPD was cultured at standard conditions for 2 
days, and placed on 4oC for 1 week to develop color. Ade was cultured for 7 days. 
 
 DOA4+ UBP6+ 
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The [PSI+][PIN+] versions of a UBC4+, DOA4+ strain, a ubc4∆ strain, a dao4∆ 
strain, and the ubc4, doa4∆ strain were transformed with a plasmid containing HSP104 
expressed under the GPD promoter and a LEU marker and also a control plasmid that 
contained only the LEU marker.  Several colonies were selected from the transformation 
plates and were patched onto media lacking leucine.  These plates were cultured at 
standard conditions for 5 days, and were then duplicated by velveteen onto YPG, media 
lacking adenine, media lacking leucine, media lacking both adenine and leucine, and 
YPD.  The curing was assessed by examination of the color of the patches on YPD.  
Lack of growth on adenine is not an efficient method to determine curing in the doa4∆ 
strain because of the severe nonsense suppression that is characteristic of this strain.  
Growth on media lacking adenine is only useful to double check controls. (For a detailed 

























Doa4 is one of the proteins responsible for the removal of ubiquitin from proteins 
prior to degradation by the proteasome.  The deletion of doa4 or ubp6 results in a defect 
in the suppression of the nonsense mutation in the ADE1 gene. (Chernova et al., 2003, 
Figure 3.10.  Curing of ubc4, doa4∆ strain by HSP104 expressed under the 
GPD Promoter. Strains GT81-1C, Wild Type, GT349, ubc4∆,  OT144, doa4∆, and 
GT538-7A, ubc4,doa4∆ were transformed with YEp13, an empty vector plasmid 
and pLH105, the plasmid expressing HSP104 under the GPD promoter   
Transformants were cultured on Leu and then duplicated by velveteen onto Ade 
and YPD. The YPD seen above was cultured at standard conditions for 2 days and 
placed at 4oC for 1 week for color development.  Curing is almost totally eliminated 
in the double deletion strain.  A slight decrease in curing efficiency is seen in doa4∆
strain, but not in the ubc4∆ deletion strain.  The red colony on the right most likely 
represents a spontaneous loss of [PSI+] that may occur as a result of the 







JBC 278:52). This phenotype, and others, are much more prevalent in the doa4∆ strain.  
This strain, unlike the ubp6∆ strain, fails to grow on media containing galactose as the 
sole carbon source.  Therefore, it was necessary to use an alternative promoter to 
control the expression of HSP104. 
 Since the phenotypes are much stronger in cells lacking the Doa4, 
deubiquitinating enzyme, relative to the ubp6∆ strain, it is predictable that the efficiency 
of curing would be affected to a greater extent than that of ubp6∆ strain.  The results 
support this prediction.  Curing was almost eliminated in the double deletion strain, and 
slightly decreased in the doa4∆ strain. 
 Since the deletion of ubp4 inhibits the removal of ubiquitin from protein prior to 
degradation, the level of free ubiquitin in the cells in substantially decreased.  This 
decreases the amount of ubiquitin available for conjugating enzymes.  The deletion of 
ubc4 inhibits the conjugation of ubiquitin to proteins marked for degradation.  The 
decreased ubiquitin pool and the further inhibition of conjugation by elimination of the 
enzyme responsible for conjugation should result in a magnified effect on curing 
efficiency.  This is what is seen by the near elimination of curing by HSP104 over 
expression in the double deletion strain.  The results further support the role of the 
ubiquitin-proteasome system in curing by the over expression of HSP104. 
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Additional Phenotypes of the doa4∆ strain 
Temperature Sensitivity 
 Serial dilutions of the doa4∆ strain, the ubc4∆ strain and the wild type strain, all 
[PSI+], were created.  These dilutions were used to create spots on YPD media, and 
then the plates were cultured at 25oC, 30oC, and 37oC for three days. 
 Growth of all three strains was similar at both 25oC and 30oC.   Growth was 
eliminated in the doa4∆ strain at 37oC, but even more interesting is that the growth was 
partially restored in the ubc4, doa4 double deletion strain.  This supports the conclusion 
that these two genes code for proteins that act in the same pathway.  When ubiquitin 
conjugation is inhibited, the free pool of ubiquitin is increased.  This decreases 




























Figure 3.11.  Growth of the doa4∆ and ubc4∆ strains. Dilution spots of 
OT144,doa4∆, GT349, ubc4∆, and GT81-1C, Wild Type, strains were 
cultured at 25oC and 30oC and 37oC for 4 days.  There does not appear to 
be any difference between the four strains at either 25oC or 30oC 
temperature. Growth was eliminated in the doa4∆ strain at 37oC, but shows 
some restoration in the double deletion strain.  The levels of free ubiquitin 
may be elevated in the ubc4,doa4∆ strain compared to that of the doa4∆ 























Figure 3.11 Continued 
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Growth of doa4∆ on media with galactose as sole carbon source 
Strains GT81-1C, Wild Type GT349, ubc4∆, OT144, doa4∆, and OT116, ubp6 ∆ 
strains were transformed with pGAL104, a plasmid that contains HSP104 expressed 
under the galactose promoter, and pRS316GAL, and empty vector plasmid in an 
attempt to asses curing by Hsp104.  The transformation was plated on Ura and 
cultured at standard conditions for 5 days Colonies were selected and patched on Ura, 
cultured, and then duplicated by veleveteen onto Ura with 2% galactose as the sole 
carbon source.  The doa4∆ strain failed to grow after 7 days.  An Ura plate was then 
again duplicated on Ura media that contained 2% galactose and 2% raffinose as the 
carbon sources. The doa4∆ strain failed to grow after 7 days.   This eliminated the use 
of the galactose inducible promoter for experimentation with the doa4∆ strain.    (For 
detailed protocol for curing with HSP104 under the galactose promoter, see Material 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Construction of Strains for This Study 
 
Strain Construction 
GT349 PCR-mediated gene transplacement was 
accomplished using plasmid pFA6A-HIS3MX6  to 
displace UBC4 with HIS3 in the strain GT81-1C  
GT386 GT349 cured by HSP104 over expression 
GT387 GT349 cured by GuHCl 
GT685 OT116 cured by GuHCl 
GT823 GT398-14A cured by HSP104 over expression 
GT563 PCR-mediated gene transplacement was 
accomplished using plasmid pFA6A-HIS3MX6  to 
displace RNQ1 with HIS3 in the strain GT81-1C 
GT564 PCR-mediated gene transplacement was 
accomplished using plasmid pFA6A-HIS3MX6  to 
displace RNQ1 with HIS3 in the strain GT159 
GT832-7B Cross and dissection of OT116 and GT532-9C 
GT532-9C Created by a cross between GT580 (ubc4::HIS3) and 
GT385-13A (ubc4::HIS3) for previous research. 
GT949 GT832-7B cured by HSP104 over expression 
GT950 GT832-7B cured by GuHCl 
GT784-8B Cross and dissection between GT563 and GT532-9C 
GT389-14A Cross GT127 (ssb1::HIS3, ssb2::URA3) and GT385-
13A (ubc4::HIS3) 
GT820 GT784-8B cured by HSP104 over expression 
 
 




PGAL104 was cut with HXO1 and SAC1.  The entire HSP104 under the 
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